Midterm Results of Radiofrequency Ablation for Incompetent Small Saphenous Vein in Terms of Recanalization and Sural Neuritis. Issue 4 (20th February 2014)

• Record Type: Journal Article
• Authors: Park, Jae Young; Galimzahn, Azimbaev; Park, Hyung Sub; Yoo, Young Sun; Lee, Taeseung
• Is Part Of: Dermatologic surgery. Volume 40:Issue 4(2014)
• Page Start: 383
• Page End: 389
• Publication Date: 2014-02-20
• Subjects: Skin -- Surgery -- Periodicals; Skin -- Diseases -- Surgery -- Periodicals; 617.477
• DOI: 10.1111/dsu.12456
• Languages: English
• ISSNs: 1076-0512

Abstract

<abstract abstract-type="main" id="dsu12456-abs-0001"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="dsu12456-sec-0001" sec-type="section"> <title>Background</title> <p>Safety and effectiveness of radiofrequency ablation for incompetent small saphenous vein is not established.</p> </sec> <sec id="dsu12456-sec-0002" sec-type="section"> <title>Objective</title> <p>To report midterm clinical and ultrasonograhic results of radiofrequency ablation (RFA) for small saphenous vein (SSV) in terms of recanalization and sural neuritis.</p> </sec> <sec id="dsu12456-sec-0003" sec-type="section"> <title>Methods and materials</title> <p>We examined 39 patients (46 limbs) who had been examined using a duplex scan more than 1 year after RFA of SSV. Postoperative clinical results, risk factors for SSV recanalization, and sural neuritis were analyzed.</p> </sec> <sec id="dsu12456-sec-0004" sec-type="section"> <title>Results</title> <p>CEAP score and CIVIQ2 score improved significantly in all patients (CEAP: 2.45 to 1.43 (<italic>p</italic> = .03); CIVIQ2: 25.34 to 13.21 (<italic>p</italic> = .01). SSV obliteration rate was 93.4% at 1 year and 89.1% at 2 years. Preoperative peak reflux velocity in the recanalization group (54.9 cm/s) was significantly higher (<italic>p</italic> < .01) than in the obliteration group (29.8 cm/s). Sural neuritis were detected in 12 limbs (26.1%), and median symptom duration was 3 months. The total length of RFA ablation was not different between the groups with and without postablation sural neuritis.</p> </sec> <sec id="dsu12456-sec-0005" sec-type="section"> <title>Conclusion</title> <p>RFA is an effective and safe treatment modality for incompetent SSV. Peak reflux velocity can be a risk factor for recanalization. Length of RFA segment in SSV does not affect recanalization and postablation sural neuritis.</p> </sec> </abstract>